SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-032371
Filing Date
2018-06-01
Accepted
2018-06-01 16:06:01
Documents
6
Period of Report
2018-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv495357_8k.htm 8-K 53357
2 EXHIBIT 3.1 tv495357_ex3-1.htm EX-3.1 31043
3 EXHIBIT 10.1 tv495357_ex10-1.htm EX-10.1 111726
4 EXHIBIT 10.2 tv495357_ex10-2.htm EX-10.2 56108
5 EXHIBIT 10.3 tv495357_ex10-3.htm EX-10.3 37895
6 EXHIBIT 10.4 tv495357_ex10-4.htm EX-10.4 39900
  Complete submission text file 0001144204-18-032371.txt   331537
Mailing Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 18875116
SIC: 2834 Pharmaceutical Preparations